STAT

Opinion: Working together, data scientists and cancer researchers can transform cancer treatment

Exposing more cancer researchers and oncologists to data science and data scientists to the complexity of cancer has the potential to transform treatment.

At a time when data and data science are increasingly essential to improving cancer care, oncologists and cancer researchers often lack the training needed to understand and leverage the data to their fullest extent. Similarly, data scientists often lack an understanding of cancer biology and a patient’s journey through the disease, both of which are necessary to gather and query data appropriately to answer a myriad of important biological and clinical questions.

Take, for example, a case recently discussed at a big data meeting hosted by Susan G. Komen, the organization we work for: A data scientist

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks